Ah, vabbe', se sei sicuro allora è sicuramente così, mi sembra una motivazione validissima.
Oral finasteride is a well‐established treatment for men with androgenetic alopecia (AGA), but long‐term therapy is not always acceptable to patients. A topical finasteride formulation has been developed to minimize systemic exposure by acting ...
pmc.ncbi.nlm.nih.gov
”Treatment‐related sexual adverse events (sexual dysfunction, erectile dysfunction, libido decreased, loss of libido) were reported in 2.8% vs. 3.3% vs. 4.8% of patients treated with topical finasteride, placebo, or oral finasteride. Discontinuations due to treatment‐related sexual adverse events were reported in 0% vs. 1.1% vs. 2.4% of patients, respectively."